Skip to main content
Clinical Trials/ISRCTN15835424
ISRCTN15835424
Completed
Not Applicable

A randomised controlled feasibility trial to investigate the timing of HDR Brachytherapy with EBRT in intermediate and high risk localised prostate cancer patients and its effects on toxicity and quality of life

Southend University Hospital NHS Foundation Trust0 sites50 target enrollmentApril 10, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostate cancer
Sponsor
Southend University Hospital NHS Foundation Trust
Enrollment
50
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Registry
who.int
Start Date
April 10, 2015
End Date
January 1, 2017
Last Updated
7 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Southend University Hospital NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient age \>18 years
  • 2\. Histologically diagnosed Prostate cancer, stages T1b\-T3bN0M0
  • 3\. Any Gleason score
  • 4\. Any PSA level
  • 5\. Patient able to consent and fill in the questionnaires

Exclusion Criteria

  • 1\. Previous TURP/HoLEP Laser Prostatectomy
  • 2\. Any Metastatic Disease
  • 3\. IPSS\>20
  • 4\. Pubic arch interference
  • 5\. Lithotomy position
  • 6\. If Anaesthesia is not possible
  • 7\. Rectal fistula
  • 8\. Prior pelvic radiotherapy

Outcomes

Primary Outcomes

Not specified

Similar Trials